Ignite Creation Date:
2024-05-06 @ 9:04 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02898116
Status:
COMPLETED
Last Update Posted:
2022-10-10
First Post:
2016-09-08
Brief Title:
Phase 12 Study of Ensartinib and Durvalumab in ALK-rearranged Non-small Cell Lung Cancer
Sponsor:
Ludwig Institute for Cancer Research
Organization:
Ludwig Institute for Cancer Research